China's vaccine group CanSino HK stock at over 5-months low amid yearly loss

Cansino Biologics

28/03/2023 08:27

** Hong Kong shares of China's vaccine producer CanSino
Biologics Inc  6185.HK  fall as much as 5.9% to HK$44.80, their
lowest since Oct. 14, 2022 
    ** Tianjin-based CanSino posts net loss of 909.4 mln yuan
($132.13 million) for 2022 as compared with a net profit of 1.9
bln yuan in the previous year 
    ** Says 2022 revenue down 76% year-on-year at 1.03 bln yuan
amid a decrease in demand for COVID-19 vaccines in overseas
markets as global COVID-19 vaccination rate growth slows 
    ** Shanghai-listed shares  688185.SS  fall 2.3% 
    ** The Hang Seng Commerce & Industry Index  .HSNC  rises 1%
while the healthcare index  .HSCIH  falls 1.4%
    ** The Hang Seng Composite Index  .HSCI  and the Hang Seng
Index  .HSI  both gain 1.1%

($1 = 6.8825 Chinese yuan renminbi)

 (Reporting by Donny Kwok, Editing by Louise Heavens)
 ((donny.kwok@thomsonreuters.com))